Event Details
34th Annual General Meeting (AGM) scheduled for Tuesday, September 29, 2026 at 3:00 P.M. (IST) to be held through video conference/other audio visual means.
Cut-off Date for E-voting: Tuesday, September 22, 2026
Remote E-voting Period: Saturday, September 26, 2026 at 9:00 A.M. to Monday, September 28, 2026 at 5:00 P.M.
Business to be Transacted
Ordinary Business:
1. To receive, consider and adopt the Audited Financial Statements for FY 2025-26 including Balance Sheet, Statement of Profit & Loss, Cash Flow Statement, Board's Report and Statutory Auditor's Report
2. To appoint a director in place of Mr. Jitendra Prabhakar Nene (DIN: 06814833) who retires by rotation
Financial Performance (FY 2025-26 vs FY 2024-25)
| Particulars | 2025-26 (₹ Lakhs) | 2024-25 (₹ Lakhs) |
| Sales Turnover | 135.50 | 26.52 |
| Other Income | 7.02 | 0 |
| Total Income | 142.52 | 26.52 |
| Total Expenditure | 108.88 | 12.63 |
| Profit before Tax | 33.64 | 13.89 |
| Taxes | 7.70 | 2.08 |
| Net Profit after Tax | 25.94 | 11.81 |
| Dividend | 0.00 | 0.00 |
Share Capital Details
Authorized Share Capital: ₹11,00,00,000 divided into 1,10,00,000 equity shares of ₹10 each
Paid-up Share Capital: ₹8,40,89,720 divided into 84,08,972 equity shares of ₹10 each
Rights Issue Completed: 80,85,550 fully paid-up equity shares of face value ₹10 each issued at ₹10 per share through Board resolution dated August 16, 2026. Issue made to public shareholders in ratio of 25:1 (25 Rights Equity Shares for every 1 fully paid-up equity share held) to facilitate compliance with minimum public shareholding norms.
After March 31, 2025, Authorized Share Capital increased from ₹11,00,00,000 to ₹25,00,00,000 divided into 2,50,00,000 Equity Shares of ₹10 each vide members resolution dated May 22, 2026
Corporate Changes
Change in Registered Office:
- From State of Telangana to State of Maharashtra (completed August 26, 2025)
- Within Pune from "Office No. 4, Kumar Prestige Point, 238 Shukrawar Peth" to "Office No.A1-1202, 12th Floor, Boulevard Tower, Phase-2, CTS No. 11, Sadhu Vaswani Chowk, Camp, Pune" (effective March 10, 2026)
Change in Company Name: From Covidh Technologies Limited to iSERA Lifesciences Limited vide members resolution dated April 02, 2026
Board of Directors (as on March 31, 2026)
| Name | Designation | Date of Appointment |
| Jayshree Suresh Jain | Managing Director | 28/08/2024 |
| Jitendra Prabhakar Nene | Non-Executive Director | 24/10/2024 |
| Rinku Saini | Independent Director | 01/08/2025 |
| Mangina Srinivas Rao | Independent Director | 30/05/2025 |
Key Managerial Personnel
| Name | Designation | Date of Appointment |
| Jayshree Suresh Jain | Managing Director | 28/08/2024 |
| Vishal Vinod Jain | Chief Financial Officer | 30/05/2025 |
| Deepakshi | Company Secretary & Compliance Officer | 10/09/2025 |
Board Changes During FY 2025-26
Appointments:
- Jayshree Suresh Jain (MD) - 28.08.2024
- Jitendra Prabhakar Nene (Non-Executive) - 24.10.2024
- Vishal Vinod Jain (CFO) - 30.05.2025
- Rinku Saini (Independent) - 01.08.2025
- Mangina Srinivas Rao (Independent) - 30.05.2025
Resignations/Cessations:
- Ms. Apurva Pradeep Joshi (Independent) - 14.08.2025
- Mr. Narsi Reddy Ganapa (Executive Director Chairperson) - 04.07.2025
- Mr. Sivaji Gopalam (Independent) - 04.07.2025
- Mr. Ganesh Amirineni (Independent) - 04.07.2025
- Ms. Hema Kumari - 04.07.2025
Post-Year End Director Appointments (April 02, 2026)
- Mr. Dhairyasheel Vasantrao Yadav (DIN: 07551888) as Executive Director for 5 years
- Nandkumar Subhash Kadam (DIN: 07551886) as Executive Director for 5 years
- Mr. Pratap Dadasaheb Deshmukh (DIN: 07551567) as Non-Executive Director (Non-Independent) for 5 years
- Ms. Ritu Dhanraj Garad (DIN: 11503075) as Non-Executive Director (Non-Independent) for 5 years
Committee Composition
Audit Committee:
- Mangina Srinivas Rao (Chairperson)
- Rinku Saini (Member)
- Jitendra Prabhakar Nene (Member)
Nomination & Remuneration Committee:
- Mangina Srinivas Rao (Chairperson)
- Rinku Saini (Member)
- Jitendra Prabhakar Nene (Member)
Stakeholders' Relationship Committee:
- Mangina Srinivas Rao (Chairperson)
- Rinku Saini (Member)
- Jitendra Prabhakar Nene (Member)
Dividend Declaration
No dividend recommended for FY 2025-26 due to capital requirements, working capital needs and future expansion plans.
Auditors
Statutory Auditors: M/s. V Ravi & Co, Chartered Accountants (FRN: 00064928S) reappointed for 5 consecutive years ending 2030.
Secretarial Auditor: M/s. Anuj Gupta & Associates, Practicing Company Secretaries
Other Significant Information
- Number of Permanent Employees: 5
- No instances of fraud reported by Statutory Auditors
- No material orders passed by regulators/courts impacting going concern status
- No deposits accepted from public during the year
- No unpaid/unclaimed dividend with the company
- No sexual harassment complaints received during the year
Registrar & Share Transfer Agent
Skyline Financial Services Pvt. Ltd., D-153A, 1st Floor, Okhla Industrial Area, Phase-I, New Delhi - 110020
#Tags: #iSERALifesciences #AGM2026 #FY2026Results #RightsIssue #SEBIDisclosure #RegulatoryCompliance #FinancialUpdate #Neutral